All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Merrimack Pharmaceuticals, Inc. revenue reports

Merrimack Pharmaceuticals, Inc. financial reports, Merrimack Pharmaceuticals, Inc. annual revenue in 2024. When does Merrimack Pharmaceuticals, Inc. report revenue?
Add to widgets
Added to widgets

Merrimack Pharmaceuticals, Inc. total revenue, net income and dynamics of changes in US dollar today

The dynamics of net revenue of Merrimack Pharmaceuticals, Inc. rose. The change amounted to 0 $. The dynamics of net revenue is shown in comparison with the previous report. Net income Merrimack Pharmaceuticals, Inc. - -696 000 $. Information about net income is used from open sources. The dynamics of Merrimack Pharmaceuticals, Inc. net income grew by 412 000 $ for the last reporting period. The financial report chart shows the values from 30/06/2017 to 31/03/2021. Merrimack Pharmaceuticals, Inc. financial report on a graph in real time displays the dynamics, i.e. change in fixed assets of the company. The value of "net income" Merrimack Pharmaceuticals, Inc. on the graph is displayed in blue.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021 0 $ - -696 000 $ -
31/12/2020 0 $ - -1 108 000 $ -
30/09/2020 0 $ - -1 006 000 $ -
30/06/2020 0 $ - -1 163 000 $ -
30/09/2019 0 $ - -705 000 $ -
30/06/2019 0 $ - -9 430 000 $ -
31/03/2019 0 $ - -10 458 000 $ -
31/12/2018 0 $ - -8 944 000 $ -
30/09/2018 0 $ - 3 989 000 $ -
30/06/2018 0 $ - -17 769 000 $ -
31/03/2018 0 $ - -17 782 000 $ -
31/12/2017 0 $ - -12 951 000 $ -
30/09/2017 0 $ - 3 102 000 $ -
30/06/2017 0 $ - 511 563 000 $ -
Show:
to

Merrimack Pharmaceuticals, Inc. financial report charts

The dates of the latest financial statements of Merrimack Pharmaceuticals, Inc.: 30/06/2017, 31/12/2020, 31/03/2021. The dates of financial statements are strictly regulated by law and financial statements. The current date of the financial report of Merrimack Pharmaceuticals, Inc. for today is 31/03/2021. Operating income Merrimack Pharmaceuticals, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Merrimack Pharmaceuticals, Inc. is -746 000 $

Merrimack Pharmaceuticals, Inc. quarterly report dates

Net income Merrimack Pharmaceuticals, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Merrimack Pharmaceuticals, Inc. is -696 000 $ Current assets Merrimack Pharmaceuticals, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Merrimack Pharmaceuticals, Inc. is 16 250 000 $ Total assets Merrimack Pharmaceuticals, Inc. refers to the total amount of assets owned by a person or entity. Total assets Merrimack Pharmaceuticals, Inc. is 16 441 000 $

Current cash Merrimack Pharmaceuticals, Inc. - the sum of all of the cash a company has on the date of report. Current cash Merrimack Pharmaceuticals, Inc. is 13 890 000 $

31/03/2021 31/12/2020 30/09/2020 30/06/2020 30/09/2019 30/06/2019 31/03/2019 31/12/2018 30/09/2018 30/06/2018 31/03/2018 31/12/2017 30/09/2017 30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
- - - - - -2 939 000 $ -6 161 000 $ -9 231 000 $ -12 959 000 $ -13 678 000 $ - - - -
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
- - - - - 2 939 000 $ 6 161 000 $ 9 231 000 $ 12 959 000 $ 13 678 000 $ - - - -
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
- - - - - - - - - - - - - -
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - - - - - - - - - - -
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-746 000 $ -886 000 $ -1 007 000 $ -1 184 000 $ -4 446 000 $ -6 068 000 $ -9 744 000 $ -12 972 000 $ -16 736 000 $ -17 191 000 $ -17 376 000 $ -17 014 000 $ -16 964 000 $ -34 549 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-696 000 $ -1 108 000 $ -1 006 000 $ -1 163 000 $ -705 000 $ -9 430 000 $ -10 458 000 $ -8 944 000 $ 3 989 000 $ -17 769 000 $ -17 782 000 $ -12 951 000 $ 3 102 000 $ 511 563 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
- - - - - - - 49 974 000 $ 49 974 000 $ 49 974 000 $ 13 106 000 $ 12 360 000 $ 13 598 000 $ 19 751 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
746 000 $ 886 000 $ 1 007 000 $ 1 184 000 $ 4 446 000 $ 6 068 000 $ 9 744 000 $ 12 972 000 $ 16 736 000 $ 17 191 000 $ 17 376 000 $ 17 014 000 $ 16 964 000 $ 34 549 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
16 250 000 $ 16 544 000 $ 18 684 000 $ 19 366 000 $ 22 398 000 $ 42 557 000 $ 63 694 000 $ 76 102 000 $ 87 267 000 $ 61 731 000 $ 77 110 000 $ 95 046 000 $ 115 577 000 $ 141 563 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
16 441 000 $ 16 776 000 $ 18 958 000 $ 19 681 000 $ 24 841 000 $ 45 040 000 $ 74 353 000 $ 88 543 000 $ 103 916 000 $ 80 226 000 $ 97 495 000 $ 117 326 000 $ 197 847 000 $ 213 450 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
13 890 000 $ 14 038 000 $ 15 814 000 $ 15 735 000 $ 20 858 000 $ 36 917 000 $ 36 542 000 $ 20 079 000 $ 49 794 000 $ 22 460 000 $ 35 044 000 $ 93 441 000 $ 107 245 000 $ 135 501 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
- - - - 4 739 000 $ 4 940 000 $ 11 814 000 $ 14 795 000 $ 22 065 000 $ 17 894 000 $ - - - -
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - - - - - 76 266 000 $ 93 441 000 $ 107 245 000 $ 135 501 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
- - - - 4 739 000 $ 4 996 000 $ 25 389 000 $ 29 724 000 $ 36 873 000 $ 17 950 000 $ - - - -
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
- - - - 19.08 % 11.09 % 34.15 % 33.57 % 35.48 % 22.37 % - - - -
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
15 757 000 $ 16 006 000 $ 16 740 000 $ 17 346 000 $ 20 102 000 $ 40 044 000 $ 48 964 000 $ 58 819 000 $ 67 043 000 $ 62 276 000 $ 79 254 000 $ 96 284 000 $ 111 634 000 $ 106 508 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - -3 203 000 $ -11 873 000 $ -13 652 000 $ -18 892 000 $ -13 114 000 $ -16 243 000 $ -17 339 000 $ -24 790 000 $ -25 635 000 $ -85 354 000 $

Last revenue report of Merrimack Pharmaceuticals, Inc. was 31/03/2021. According to last financial report total revenue in Merrimack Pharmaceuticals, Inc. was 0 US dollar and changed by 0% since last year. Net income in Merrimack Pharmaceuticals, Inc. was -696 000 $ in last quartal, net income changes to 0%.

Merrimack Pharmaceuticals, Inc. stocks data

Merrimack Pharmaceuticals, Inc. financials